Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

The American Can Company was a manufacturer of tin cans. It was a member of the Tin Can Trust, that controlled a "large percentage of business in the United States in tin cans, containers, and packages of tin." American Can Company ranked 97th among United States corporations in the value of World War II military production contracts. It was formerly a member of the Dow Jones Industrial Average from 1959–1991, though after 1987 it had renamed itself Primerica, a financial conglomerate which had divested itself of its packaging arm in 1986.

Part of Pfizer Inc., Medivation Technologies LLC is a company headquartered in the United States. The firm manufactures compounds and compositions to treat diseases and disorders.

Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.

American Cyanamid Company was a U.S.-based diversified company with businesses in several fields. The company was a manufacturer of agricultural chemicals, cosmetics, perfumes, building products, plastics and pharmaceuticals. The company was listed as a top 100 manufacturing company by Fortune magazine in the 1970s. Cyanamid was founded in 1907 and employed over 100,000 people around the world by 2000. The company maintained a monopoly over tetracycline, an antibiotic used against bacterial infections. A theft of the organism led to the loss of the monopoly as rival companies were able to produce generic versions of the formula, leading to huge losses to the company. The company sold most of its businesses in the early 2000s and is now operated under the name Cytec.  

Lite Run has begun sales of a proprietary anti-gravity “spacesuit” for walking disability, which addresses a $630 million-dollar US institutional market. Clinical results show that patients walk more than twice as far compared to presently used harnesses. We successfully treat stroke, paraplegic, the brain injured and other gait impaired patients.

Cytonics Corporation, a biotechnology company, develops diagnostic assays focusing on musculoskeletal related pain. It offers Fibronectin Aggrecan Complex Test (FACT) for molecular discography and FACT Plus multi analyte assay for diagnosing the source of pain in the spine and joints. Additionally, the company provides proteomics research and development services. Cytonics Corporation was founded in 2006 and is based in Jupiter, Florida.

Nanjing Han Xin Pharmaceutical Technology Co., Ltd. is a private company headquartered in Nanjing, China, with domestic subsidiaries. The firm engages in research and development of drugs. It was founded in 2017. Hao Ning Zhang is the current CEO of the company.

Aventis Pharma Deutschland GmbH produces pharmaceutical products. It offers prescription drugs, human vaccines, and therapeutic proteins businesses. Aventis Pharma Deutschland plans and designs plants and process control systems in the areas of active ingredients production and finished drugs. The company is headquartered in Frankfurt am Main, Germany.

Shanghai Kinetic Medical Co., Ltd. engages in the research and development, manufacture. and sale of orthopedic implants. Its business scopes include minimally invasive vertebroplasty, trauma or spine orthopedic implants, low temperature radiofrequency, medical device trading, and medical disinfection service businesses. Its Minimally Invasive Vertebroplasty business offers clinical minimally invasive surgical treatment of vertebral body compression fractures caused by osteoporosis. Its Trauma or Spine Orthopedic Implants business provides hip prosthesis, bone cement, titanium mesh, spinal fixation, interlocking intramedullary nails, and anatomical bone plates. Its Low Temperature Radiofrequency business offers surgical energy platforms and consumables. Its Medical Device Trading operates a medical device distribution service platform. Its Medical Disinfection Service business is involved in the provision of medical services for hospitals, health service centers, and outpatient clinics. The company was founded on March 31, 2005 and is headquartered in Shanghai, China.

VisionScope Technologies, LLC is a revenue-stage medical device imaging company providing HD imaging inside patient joints, in real time , in the office or surgery center. Our company’s VisionScope Imaging (VSI) system allows gold standard diagnosis of intra-articular joint issues in usually 10-15 minutes, providing better and faster patient outcomes at a lower cost for reimbursers, all while improving the providers' bottom line.

The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.

Longhua Hospital Shanghai University of TCM, a subsidiary of Shanghai University of Traditional Chinese Medicine, is a company headquartered in Shanghai, China. The firm provides hospital services.

Metabolic Technologies, Inc. is an American private company. The firm operates as a research company.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Tianjin Ruibosi Biotechnology Co., Ltd., established on 2018-04-09, Business scope includes animal cloning technology,development of biotechnology,transfer,consultation service;biomedical products,biomaterials,R&D of medical devices,technical consulting,technology transfer,Technical Services;Self-operated and agent technology import and export;cosmetic,Test reagents and consumables,medicine(Carry out business activities with a license),pet supplies,Wholesale and retail of pet food(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)